Search results
Company profile page for EPIRUS Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact information.
10 mar 2022 · A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a...
16 kwi 2014 · Zalicus (ZLCS) soared Wednesday after the biopharmaceutical company announced it would merge with Epirus Biopharmaceuticals.
19 mar 2012 · It's clear that you recognize a bargain when you see one, Leon. Thus, I'm prepared to sell you 1000 shares of ZLCS for only $3.50/share, which is fully 12.5% BELOW your lowest price target.
Find the latest (ZLCS) stock quote, history, news and other vital information to help you with your stock trading and investing.
ZLCS - Forecast, Price Target, Estimates, Predictions. ... Highest Cost to Borrow; Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand.
28 mar 2011 · Early Friday morning, JMP Securities issued a "Market Outperform" rating for Zalicus Inc. (ZLCS) and a "target" of $5 per share. Shares jumped 5%-6% on the JMP Securities news following the...